...A. We have kicked off a couple of years ago a program, which we called Accelerate 2.0. B. You have seen nice improvements in our P&Ls as an outcome of that. C. We have delivered and aim for [$0.9 billion to $1 billion] in revenue this year. D. We are about 34% of the Bruker's total revenue with about 2,800 employees globally and one of the growth drivers. E. So after a lot of consolidations in the 2013, 2014 years, we are down to about high-focused, lean operating 5 factories. F. And in Billerica here, near to Boston, our new division, which we just recently created, a Bruker Applied Mass Spectrometry division. G. We have large -- the largest installed base of mass spectrometry in applied clinical use. H. The instrument sales these days due to the large installed base of more than 7,000 units, of course, is composed, half we sell per year into market expansion and the other half is already replacement business. I. Our Bruker Life Science Mass spectrometry is known for its innovation. J....
